Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk

Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation, 67, 968, 10.1161/01.CIR.67.5.968 Van de Voorde, 2013, Adipocytokines in relation to cardiovascular disease, Metab Clin Exp, 62, 1513, 10.1016/j.metabol.2013.06.004 Kadoglou, 2010, Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes, Exp Clin Endocrinol Diabetes, 118, 75, 10.1055/s-0029-1237360 Dahl, 2007, Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization, Circulation, 115, 972, 10.1161/CIRCULATIONAHA.106.665893 Chen, 2010, Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells, Am J Physiol Heart Circ Physiol, 299, H193, 10.1152/ajpheart.00431.2009 Shai, 2005, A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes, Diabetes Care, 28, 1376, 10.2337/diacare.28.6.1376 Yang, 2006, Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action, Am J Physiol Endocrinol Metab, 290, E1253, 10.1152/ajpendo.00572.2004 Komiya, 1998, Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice, Biochem Biophys Res Commun, 251, 759, 10.1006/bbrc.1998.9513 de Souza Batista, 2007, Omentin plasma levels and gene expression are decreased in obesity, Diabetes, 56, 1655, 10.2337/db06-1506 Pan, 2010, Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes, Diabetes Res Clin Pract, 88, 29, 10.1016/j.diabres.2010.01.013 Yan, 2011, Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus, Exp Clin Endocrinol Diabetes, 119, 257, 10.1055/s-0030-1269912 Kazama, 2012, Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells, Eur J Pharmacol, 686, 116, 10.1016/j.ejphar.2012.04.033 Yamawaki, 2010, Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels, Biochem Biophys Res Commun, 393, 668, 10.1016/j.bbrc.2010.02.053 Greulich, 2013, Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies, PLoS One, 8, e59697, 10.1371/journal.pone.0059697 Shibata, 2011, Circulating omentin is associated with coronary artery disease in men, Atherosclerosis, 219, 811, 10.1016/j.atherosclerosis.2011.08.017 Moreno-Navarrete, 2010, Circulating omentin concentration increases after weight loss, Nutr Metab, 7, 27, 10.1186/1743-7075-7-27 Prats-Puig, 2011, Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children, Obesity, 19, 1905, 10.1038/oby.2011.198 Pedersen, 2012, Muscles, exercise and obesity: skeletal muscle as a secretory organ, Nat Rev Endocrinol, 8, 457, 10.1038/nrendo.2012.49 Pedersen, 2003, Searching for the exercise factor: is IL-6 a candidate?, J Muscle Res Cell Motil, 24, 113, 10.1023/A:1026070911202 Bostrom, 2012, A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, Nature, 481, 463, 10.1038/nature10777 Huh, 2012, FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise, Metab Clin Exp, 61, 1725, 10.1016/j.metabol.2012.09.002 Moreno-Navarrete, 2013, Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance, J Clin Endocrinol Metab, 98, E769, 10.1210/jc.2012-2749 Stengel, 2013, Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity — correlation with body mass index, Peptides, 39, 125, 10.1016/j.peptides.2012.11.014 Park, 2014, Diet quality is associated with circulating C-reactive protein but not irisin levels in humans, Metab Clin Exp, 63, 233, 10.1016/j.metabol.2013.10.011 Vamvini, 2013, Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans, Eur J Endocrinol, 169, 829, 10.1530/EJE-13-0276 Crujeiras, 2014, Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients, Metabolism, 63, 520, 10.1016/j.metabol.2013.12.007 Choi, 2013, Serum irisin levels in new-onset type 2 diabetes, Diabetes Res Clin Pract, 100, 96, 10.1016/j.diabres.2013.01.007 Liu, 2013, Lower circulating irisin is associated with type 2 diabetes mellitus, J Diabetes Complicat, 27, 365, 10.1016/j.jdiacomp.2013.03.002 Park, 2013, Circulating irisin in relation to insulin resistance and the metabolic syndrome, J Clin Endocrinol Metab, 98, 4899, 10.1210/jc.2013-2373 Mora, 2009, Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women, Circulation, 119, 931, 10.1161/CIRCULATIONAHA.108.816181 Krauss, 2010, Lipoprotein subfractions and cardiovascular disease risk, Curr Opin Lipidol, 21, 305, 10.1097/MOL.0b013e32833b7756 Buysse, 1989, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research, Psychiatry Res, 28, 193, 10.1016/0165-1781(89)90047-4 Carpenter, 1998, Psychometric evaluation of the Pittsburgh Sleep Quality Index, J Psychosom Res, 45, 5, 10.1016/S0022-3999(97)00298-5 Dipietro, 1993, A survey for assessing physical activity among older adults, Med Sci Sports Exerc, 25, 628, 10.1249/00005768-199305000-00016 Jeyarajah, 2006, Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy, Clin Lab Med, 26, 847, 10.1016/j.cll.2006.07.006 Harris, 2009, Research electronic data capture (REDCap) — a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 Huh, 2014, Irisin in response to acute and chronic whole-body vibration exercise in humans, Metabolism, 63, 918, 10.1016/j.metabol.2014.04.001 Bostrom, 2014, Metabolism: irisin, the metabolic syndrome and follistatin in humans, Nat Rev Endocrinol, 10, 11, 10.1038/nrendo.2013.230 Polyzos, 2013, Irisin: a renaissance in metabolism?, Metab Clin Exp, 62, 1037, 10.1016/j.metabol.2013.04.008 Roca-Rivada, 2013, FNDC5/irisin is not only a myokine but also an adipokine, PLoS One, 8, e60563, 10.1371/journal.pone.0060563 Erickson, 2013, Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor?, Adipocyte, 2, 289, 10.4161/adip.26082 Raschke, 2013, Evidence against a beneficial effect of irisin in humans, PLoS One, 8, e73680, 10.1371/journal.pone.0073680 Bostrom, 2014, Irisin in humans: recent advances and questions for future research, Metab Clin Exp, 63, 178, 10.1016/j.metabol.2013.11.009 Gouni-Berthold, 2013, Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo, PLoS One, 8, e72858, 10.1371/journal.pone.0072858 de la Iglesia, 2013, Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients, Clin Endocrinol Lehti, 2013, High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice, Circulation, 128, 2364, 10.1161/CIRCULATIONAHA.113.001551 Moreno-Navarrete, 2011, Circulating omentin as a novel biomarker of endothelial dysfunction, Obesity, 19, 1552, 10.1038/oby.2010.351 Bremer, 2013, Adipose tissue dysfunction in nascent metabolic syndrome, J Obes, 8 Jialal, 2013, Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome, J Clin Endocrinol Metab, 98, E514, 10.1210/jc.2012-3673 Yoo, 2013, Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus, Endocrine, 44, 680, 10.1007/s12020-013-9930-1 Shibata, 2011, Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men, Hypertens Res, 34, 1309, 10.1038/hr.2011.130 Yamawaki, 2011, Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells, Biochem Biophys Res Commun, 408, 339, 10.1016/j.bbrc.2011.04.039 Auguet, 2011, New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women, BMC Med Genet, 12, 60, 10.1186/1471-2350-12-60 Blüher, 2014, Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children, Obesity, 22, 1701, 10.1002/oby.20739 Yan, 2014, Association of serum irisin with metabolic syndrome in obese Chinese adults, PLoS One, 9, e94235, 10.1371/journal.pone.0094235